Contact this trialFirst, we need to learn more about you.
Chemotherapy
Navtemadlin + Decitabine for Acute Myeloid Leukemia
Recruiting1 awardPhase 1
Baltimore, Maryland
This trial is testing navtemadlin + decitabine to treat patients with AML that has come back, does not respond to treatment, or is newly diagnosed. Navtemadlin blocks enzymes needed for cell growth. Decitabine works in different ways to stop the growth of cancer cells. Giving navtemadlin and decitabine together may work better than decitabine alone.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.